121 related articles for article (PubMed ID: 7537533)
21. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
22. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.
Tseng SY; Otsuji M; Gorski K; Huang X; Slansky JE; Pai SI; Shalabi A; Shin T; Pardoll DM; Tsuchiya H
J Exp Med; 2001 Apr; 193(7):839-46. PubMed ID: 11283156
[TBL] [Abstract][Full Text] [Related]
23. Expression and functional significance of an additional ligand for CTLA-4.
Lenschow DJ; Su GH; Zuckerman LA; Nabavi N; Jellis CL; Gray GS; Miller J; Bluestone JA
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11054-8. PubMed ID: 7504292
[TBL] [Abstract][Full Text] [Related]
24. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
Linsley PS; Brady W; Grosmaire L; Aruffo A; Damle NK; Ledbetter JA
J Exp Med; 1991 Mar; 173(3):721-30. PubMed ID: 1847722
[TBL] [Abstract][Full Text] [Related]
25. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS
Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963
[TBL] [Abstract][Full Text] [Related]
26. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel MF; Allison JP
J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
[TBL] [Abstract][Full Text] [Related]
27. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
28. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
[TBL] [Abstract][Full Text] [Related]
29. Differential T-cell activation by B7-1 expression.
Li W; Rosenzweig A; Huber BT
Immunology; 2003 Jul; 109(3):336-42. PubMed ID: 12807478
[TBL] [Abstract][Full Text] [Related]
30. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
[TBL] [Abstract][Full Text] [Related]
31. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
[TBL] [Abstract][Full Text] [Related]
32. Expression of the co-stimulatory molecule B7 on melanoma cells.
Hersey P; Si Z; Smith MJ; Thomas WD
Int J Cancer; 1994 Aug; 58(4):527-32. PubMed ID: 7520026
[TBL] [Abstract][Full Text] [Related]
33. Costimulation and its role in organ transplantation.
Bluestone JA
Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
[TBL] [Abstract][Full Text] [Related]
34. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.
Wagner DH; Hagman J; Linsley PS; Hodsdon W; Freed JH; Newell MK
J Exp Med; 1996 Nov; 184(5):1631-8. PubMed ID: 8920853
[TBL] [Abstract][Full Text] [Related]
35. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.
Sica GL; Choi IH; Zhu G; Tamada K; Wang SD; Tamura H; Chapoval AI; Flies DB; Bajorath J; Chen L
Immunity; 2003 Jun; 18(6):849-61. PubMed ID: 12818165
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
Kubin M; Kamoun M; Trinchieri G
J Exp Med; 1994 Jul; 180(1):211-22. PubMed ID: 7516408
[TBL] [Abstract][Full Text] [Related]
37. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.
Gimmi CD; Freeman GJ; Gribben JG; Gray G; Nadler LM
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6586-90. PubMed ID: 7688125
[TBL] [Abstract][Full Text] [Related]
38. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
Fallarino F; Fields PE; Gajewski TF
J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
[TBL] [Abstract][Full Text] [Related]
39. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
40. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
Prud'homme GJ; Chang Y; Li X
Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
